Roche Diagnostics to establish its Middle East regional headquarters in JafzaJan 28, 2012 - 12:26 -
WAM DUBAI, Jan 28th, 2012 (WAM) :Roche Diagnostics, diagnostic division of global healthcare company Roche announced that it will set up its Middle East headquarters in Jafza and commence operations next month. The announcement was made on the sidelines of healthcare exhibition and medical congress, Arab Health in Dubai today.
Although the global specialist in in-vitro diagnostics has been present in the Middle East region for more than 30 years, the Regional Headquarters in Jafza will be Roche Diagnostics' first facility in the Middle East.
Through a strong distributor network, Roche Diagnostics has a presence in 18 markets in the Middle East with a 20-25% market share in all of these markets.
Recognising the potential of the Middle East region, Roche Diagnostics seeks to increase the quality of supply and strengthen relations with distributors and end customers by providing added support and information, said a release.
In the UAE, Roche Diagnostics enjoys a continuous relationship with its long-term distributor Pharmatrade through 30 years.
Ibrahim Aljanahi, Deputy CEO, Jafza and Chief Commercial Officer said: "We are pleased to host a respected Fortune 500 Company such as Roche at Jafza. Roche is a leader in research-focused healthcare with an impressive regional presence and we believe Jafza's unmatched connectivity, logistics and commercial advantages will support its growth in the region.
"The Middle Eastern region is a very important part of our business. We see a tremendous potential for growth in the Middle East. Therefore, we decided to open our regional headquarters in Dubai as a hub to serve our Middle Eastern countries. Jafza is one of the leading drivers in the UAE economy and Roche Diagnostics will benefit from the advantages that come with being part of a growing business community." said Dr. Michael Heuer, President EMEA-LATAM, Roche Diagnostics.